CS logo
small CS logo
Emory University School of Medicine

Atlanta, Georgia, United States
Medical school in Atlanta, Georgia
201 Dowman Dr, Atlanta, GA 30322

About Emory University School of Medicine


The Emory University School of Medicine is the graduate medical school of Emory University and a component of Emory’s Robert W. Woodruff Health Sciences Center. Before it was established as the Emory School of Medicine in 1915, the school first began as the Atlanta Medical College.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Emory University
26
Pfizer
9
National Institute of Allergy and Infectious Diseases (NIAID)
8
Centers for Disease Control and Prevention
7
Bristol-Myers Squibb
5
Duke University
5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
5
Shire
5
Genzyme, a Sanofi Company
4
Mitsubishi Tanabe Pharma America Inc.
4
Novartis Pharmaceuticals
4
Total Rows: 100

Clinical Trials at Emory University School of Medicine


During the past decade, Emory University School of Medicine conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 80 clinical trials were completed, i.e. on average, 75.5% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 39 clinical trials were completed. i.e. 114.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1212111120201515141412121515779933121299881313131388Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
Completed
50
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
1993-04-01
Completed
250
The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children
1994-12-01
Completed
400
A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients
Completed
The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)
Completed
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
Completed
A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients
Completed
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
Completed

Rows per page:

1–100 of 275

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Emory University School of Medicine" #1 sponsor was "Emory University" with 26 trials, followed by "Pfizer" with 9 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 8 trials sponsored, "Centers for Disease Control and Prevention" with 7 trials sponsored and "Bristol-Myers Squibb" with 7 trials sponsored. Other sponsors include 215 different institutions and companies that sponsored additional 160 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Emory University School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator, "Emory University" with 13 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 9 trials as a collaborator and "National Institutes of Health (NIH)" with 6 trials as a collaborator. Other collaborators include 238 different institutions and companies that were collaborators in the rest 174 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Emory University School of Medicine


According to Clinical.Site data, the most researched conditions in "Emory University School of Medicine" are "HIV Infections" (15 trials), "Fabry Disease" (9 trials), "Sickle Cell Disease" (8 trials), "Stroke" (8 trials) and "Heart Failure" (7 trials). Many other conditions were trialed in "Emory University School of Medicine" in a lesser frequency.

Clinical Trials Intervention Types at Emory University School of Medicine


Most popular intervention types in "Emory University School of Medicine" are "Drug" (170 trials), "Biological" (38 trials), "Other" (27 trials), "Device" (21 trials) and "Procedure" (13 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (55 trials), "placebo" (6 trials), "Fluconazole" (5 trials), "MT-1186" (4 trials) and "Hydroxyurea" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Emory University School of Medicine


The vast majority of trials in "Emory University School of Medicine" are 260 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Emory University School of Medicine


Currently, there are NaN active trials in "Emory University School of Medicine". undefined are not yet recruiting, 34 are recruiting, 28 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 176 completed trials in Emory University School of Medicine, 4 suspended trials, and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Emory University School of Medicine, 23 "Phase 1" clinical trials were conducted, 89 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 43 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status